资讯

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca's BEYFORTUS (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and ...